{"schema_version":"secwatch.filing_event.v1","accession":"0001171843-23-006473","form_type":"8-K","ticker":"EXPO","cik":"0000851520","company_name":"EXPONENT INC","filed_at":"2023-10-26T23:59:59+00:00","discovered_at":"2026-05-14T18:03:32.158930+00:00","generated_at":"2026-06-09T09:22:53.342124+00:00","sec_items":["2.02","7.01","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Exponent Q3 revenue before reimbursements $125.0M (+9% YoY); EPS $0.48 flat; full-year guidance reaffirmed","bullets":["Q3 revenues before reimbursements $125.0M (+9% YoY); net income $24.5M ($0.48 diluted EPS) vs $24.4M ($0.47) prior year.","Engineering & other scientific segment +8% YoY; environmental & health +13%; consumer electronics softness noted.","Full-year FY2023 outlook: revenue before reimbursements high-single-digit growth; EBITDA margin 27.4%-27.8%.","Quarterly dividend $0.26/share declared, payable Dec 22, record Dec 8 (unchanged from prior rate).","Cash $137.1M at quarter end; $17.0M in share repurchases and $40.9M in dividends paid YTD."],"urls":{"canonical":"https://secwatch.observer/filing/0001171843-23-006473","json":"https://secwatch.observer/filing/0001171843-23-006473.json","markdown":"https://secwatch.observer/filing/0001171843-23-006473.md","text":"https://secwatch.observer/filing/0001171843-23-006473.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/851520/000117184323006473/0001171843-23-006473-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/851520/000117184323006473/f8k_102623.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-09T09:22:53.342124+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"f0137a7d8162ca2e9066b36d8e2ec4938d01cc2b","claim":"EXPONENT INC reported the third quarter ended September 29, 2023 results: revenue Total revenues and revenues before reimbursements for the third quarter of 2023 increased 5% to $133.3 million and 9% to, net income Net income increased to $24.5 million, EPS $0.48 per diluted share. Guidance reaffirmed.","evidence_excerpt":"Exponent, Inc. issued a press release announcing its financial results for the third quarter ended September 29, 2023.","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/851520/000117184323006473/0001171843-23-006473-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the third quarter ended September 29, 2023"},{"label":"Revenue","value":"Total revenues and revenues before reimbursements for the third quarter of 2023 increased 5% to $133.3 million and 9% to"},{"label":"Net income","value":"Net income increased to $24.5 million"},{"label":"EPS","value":"$0.48 per diluted share"},{"label":"Guidance","value":"reaffirmed"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}